Grail Inc.’s share price dropped more than 50% in premarket trading Feb. 20 after it reported late the day before that the ...

U.S. FDA approvals began 2026 at a slower pace than usual, with eight approvals recorded in January. The total falls below ...

Hand wringing over what support Europe’s biopharma sector needs to stay competitive has intensified since the European ...

Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart ...

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Angiodynamics, Briacell, Briapro, Cassava, Catheter Precision, Devonian, Johnson & Johnson, Senseonics, ...

Antibiotics specialist Bioversys AG has reported the first clinical proof-of-concept data for alpibectir (BVL-GSK098) in combination with ethionamide in pulmonary tuberculosis, with phase IIa early ...

On the average, humans – and pigs, and deer, and birds – who live at high altitudes have better blood glucose control than ...

Researchers from Shandong First Medical University (China) and collaborators have published a comprehensive study on the screening, synthesis, structure-activity relationship and biological evaluation ...

Chugai Pharmaceutical has reported a new humanized antibody (Ab, SOF-10) that targets latent TGF-β1 and selectively blocks protease- and integrin αVβ8-mediated latent TGF-β1 activation.

At a time of global transition for life sciences, with China stepping up the pace of innovation and the U.S. adopting protectionist policies, the health innovation region in Catalonia, Spain, is ...

Beijing Konruns Pharmaceutical Co. Ltd. has patented new transforming acidic coiled-coil-containing protein (TACC) inhibitors described as potentially useful for the treatment of cancer.

U.S. President Donald Trump’s foreign-imports tariff policies did not hold up well at the Supreme Court, which ruled unconstitutional his edicts under the International Emergency Economic Powers Act.